These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5135174)
1. Rate studies on in vitro dissolution and in vivo absorption of chloramphenicol. Andersgaard H; Finholt P; Gjermundsen R; Hoyland T Acta Pharm Suec; 1971 Sep; 8(4):403-14. PubMed ID: 5135174 [No Abstract] [Full Text] [Related]
2. [Bioavailability of levomycetin preparations for oral use]. Batuashvili TA; Zak AF Antibiotiki; 1983 Oct; 28(10):751-4. PubMed ID: 6651263 [TBL] [Abstract][Full Text] [Related]
3. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
4. Dissolution systems for chloramphenicol tablet bioavailability. Ogata H; Shibazaki T; Inoue T; Ejima A J Pharm Sci; 1979 Jun; 68(6):712-5. PubMed ID: 37318 [TBL] [Abstract][Full Text] [Related]
5. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270 [TBL] [Abstract][Full Text] [Related]
6. Correlation between disintegration, dissolution and in vivo absorption rate in the case of compounds with benzyl-isoquinoline structures and its pharmacokinetic aspects. Marton S; Szentmiklósi P; Rácz I Pol J Pharmacol Pharm; 1984; 36(4):385-95. PubMed ID: 6527970 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of the absorption of orally administered chloramphenicol preparations]. Finholt P; Lunde PK; Midtvedt T; Aarnes ED Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1245-6. PubMed ID: 5565809 [No Abstract] [Full Text] [Related]
8. Excretion of chloramphenicol in bile. II. Comparison of different forms of the drug used for oral administration. Havelka J Rev Czech Med; 1972; 18(4):221-7. PubMed ID: 4653248 [No Abstract] [Full Text] [Related]
9. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Souliman S; Blanquet S; Beyssac E; Cardot JM Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713 [TBL] [Abstract][Full Text] [Related]
10. Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations tested on healthy human male subjects. Bel H; Johansen H; Lunde PK; Andersgaard HA; Finholt P; Midtvedt T; Holum E; Martinussen B; Aarnes ED Pharmacology; 1971; 5(2):108-20. PubMed ID: 5570924 [No Abstract] [Full Text] [Related]
11. Rate studies on dissolution and enzymatic hydrolysis of chloramphenicol palmitate. Andersgaard H; Finholt P; Gjermundsen R; Hoyland T Acta Pharm Suec; 1974 Jun; 11(3):239-48. PubMed ID: 4839734 [No Abstract] [Full Text] [Related]
12. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study. Fujioka Y; Kadono K; Fujie Y; Metsugi Y; Ogawara K; Higaki K; Kimura T J Control Release; 2007 Jun; 119(2):222-8. PubMed ID: 17442444 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of the biological availability of chloramphenicol. Koeleman HA; Van Oudtshoorn MC S Afr Med J; 1973 Jan; 47(3):94-9. PubMed ID: 4631423 [No Abstract] [Full Text] [Related]
14. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug. Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251 [TBL] [Abstract][Full Text] [Related]
15. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates. Khan MK; Khan MF; Khan H; Mustafa G Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184 [TBL] [Abstract][Full Text] [Related]
17. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets]. Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379 [TBL] [Abstract][Full Text] [Related]
18. [Penetration of chloramphenicol into the agueous humours and cerebrospinal fluid after oral administration in horses]. Zakopal J; Hanák J; Kottman J Zentralbl Veterinarmed A; 1970 Jun; 17(6):558-64. PubMed ID: 4988388 [No Abstract] [Full Text] [Related]
19. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035 [TBL] [Abstract][Full Text] [Related]
20. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies. Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]